Literature DB >> 11158753

Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.

L Poirel1, T Lambert, S Türkoglü, E Ronco, J Gaillard, P Nordmann.   

Abstract

Two clonally unrelated Pseudomonas aeruginosa clinical strains, RON-1 and RON-2, were isolated in 1997 and 1998 from patients hospitalized in a suburb of Paris, France. Both isolates expressed the class B carbapenem-hydrolyzing beta-lactamase VIM-2 previously identified in Marseilles in the French Riviera. In both isolates, the bla(VIM-2) cassette was part of a class 1 integron that also encoded aminoglycoside-modifying enzymes. In one case, two novel aminoglycoside resistance gene cassettes, aacA29a and aacA29b, were located at the 5' and 3' end of the bla(VIM-2) gene cassette, respectively. The aacA29a and aacA29b gene cassettes were fused upstream with a 101-bp part of the 5' end of the qacE cassette. The deduced amino acid sequence AAC(6')-29a protein shared 96% identity with AAC(6')-29b but only 34% identity with the aacA7-encoded AAC(6')-I1, the closest relative of the AAC(6')-I family enzymes. These aminoglycoside acetyltransferases had amino acid sequences much shorter (131 amino acids) than the other AAC(6')-I enzymes (144 to 153 amino acids). They conferred resistance to amikacin, isepamicin, kanamycin, and tobramycin but not to gentamicin, netilmicin, and sisomicin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158753      PMCID: PMC90325          DOI: 10.1128/AAC.45.2.546-552.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Expression of the sulfonamide resistance gene from plasmid R46.

Authors:  F Guerineau; L Brooks; P Mullineaux
Journal:  Plasmid       Date:  1990-01       Impact factor: 3.466

3.  Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny.

Authors:  M L Riccio; N Franceschini; L Boschi; B Caravelli; G Cornaglia; R Fontana; G Amicosante; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Authors:  L Lauretti; M L Riccio; A Mazzariol; G Cornaglia; G Amicosante; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase.

Authors:  S Iyobe; H Kusadokoro; J Ozaki; N Matsumura; S Minami; S Haruta; T Sawai; K O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

6.  Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes.

Authors:  N Laraki; M Galleni; I Thamm; M L Riccio; G Amicosante; J M Frère; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

7.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene.

Authors:  L Poirel; T Naas; M Guibert; E B Chaibi; R Labia; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP.

Authors:  Y Hirakata; K Izumikawa; T Yamaguchi; H Takemura; H Tanaka; R Yoshida; J Matsuda; M Nakano; K Tomono; S Maesaki; M Kaku; Y Yamada; S Kamihira; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Characterization of two aminoglycoside-(3)-N-acetyltransferase genes and assay as epidemiological probes.

Authors:  F Javier Terán; M Alvarez; J E Suárez; M C Mendoza
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

View more
  62 in total

1.  First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain.

Authors:  Guillem Prats; Elisenda Miro; Beatriz Mirelis; Laurent Poirel; Samuel Bellais; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Novel 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ic, from a Pseudomonas aeruginosa integron.

Authors:  Maria Letizia Riccio; Jean-Denis Docquier; Emanuela Dell'Amico; Francesco Luzzaro; Gianfranco Amicosante; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

Authors:  Spyros Pournaras; Athanassios Tsakris; Maria Maniati; Leonidas S Tzouvelekis; Antonios N Maniatis
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Class 1 integron containing metallo-beta-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan.

Authors:  Jun Yatsuyanagi; Shioko Saito; Seizaburo Harata; Noriyuki Suzuki; Yuko Ito; Ken-Ichi Amano; Katsuhiko Enomoto
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

6.  Characterization of In100, a new integron carrying a metallo-{beta}-lactamase and a carbenicillinase, from Pseudomonas aeruginosa.

Authors:  Sandra Quinteira; João Carlos Sousa; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Leonidas S Tzouvelekis; Despoina Tokatlidou; Nicholas Spanakis; Antonios N Maniatis; Nicholas J Legakis; Athanassios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 8.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Detection of VIM-2 metallo-beta-lactamase in Pseudomonas aeruginosa from Germany.

Authors:  Beate Henrichfreise; Irith Wiegand; Kimberley J Sherwood; Bernd Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

10.  Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Ioulia Kristo; Theodore Pittaras; Nicholas Spanakis; Spyros Pournaras; Fani Markou
Journal:  J Clin Microbiol       Date:  2009-09-23       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.